# Ischemia Reperfusion: Prostaglandins and Antioxidants

> **NCT01666587** · NA · COMPLETED · sponsor: **University of Essex** · enrollment: 12 (actual)

## Conditions studied

- Ischemic Reperfusion Injury

## Interventions

- **DIETARY_SUPPLEMENT:** Antioxidant
- **DRUG:** Prostaglandin inhibitor (Ibuprophen)

## Key facts

- **NCT ID:** NCT01666587
- **Lead sponsor:** University of Essex
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-04
- **Final completion:** 2013-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666587, "Ischemia Reperfusion: Prostaglandins and Antioxidants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01666587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*